Alpha memo: metformin resistance training endpoint split

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

To resubmit, address

1. Rename or reclassify to make the modality mismatch explicit, e.g., 'metformin: resistance training molecular attenuation vs concurrent training superiority on metabolic endpoints,' so the title matches the receipt bundle.
2. Add a one-line caveat in the one-sentence alpha that Receipt 2 is concurrent (aerobic+resistance) training versus metformin, not resistance training alone, and that allocation was convenience-based with n=7.
3. Clarify that the 'context-dependent' framing rests on a cross-population, cross-modality, cross-endpoint comparison and is therefore a hypothesis-generating heterogeneous signal, not a moderator claim.
4. Optionally narrow the alpha to resist implying that metformin vs training was directly tested on resistance-training hypertrophy in the overweight/obese population, which neither receipt did.

Major issues

• The title promises a 'metformin resistance training endpoint split,' but Receipt 2 is a concurrent (aerobic + resistance) training comparison, not a resistance-training comparison, so the memo's central contrast is partly a modality mismatch rather than a clean endpoint split within resistance training.
• Receipt 2 is not a metformin-vs-placebo resistance training trial; it is a small (n=7), convenience-allocated, non-randomized comparison of concurrent training vs metformin monotherapy in overweight/obese adults, so the apparent 'training beats metformin' signal is confounded by allocation method, small sample, and the absence of a metformin+training arm.

Minor issues

• The abstract could specify that Receipt 2 is concurrent training rather than resistance training alone, since that materially changes how the contrast reads.
• The falsifier section is strong and could be lifted into the main one-sentence alpha as an explicit scope qualifier.

Reviewer note

Bounded alpha-memo with two well-matched primary receipts whose abstracts directly support the cited claims. The title/source alignment is the main defect: Receipt 2 is concurrent (aerobic+resistance) training vs metformin, not resistance training alone, so the promised 'resistance training endpoint split' is partly a modality contrast masquerading as an endpoint contrast. Receipt 2 is also small (n=7) and convenience-allocated, which the memo flags in caveats but does not surface in the one-sentence alpha. The falsifier and caveats sections are unusually explicit and honest, which raises limitations_quality. Revise to rename/reclassify and add a single-sentence modality+allocation caveat in the alpha, after which this would likely be accept-quality.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: fallback_tiebreak_failed_conservative

Prompt: reviewer-v11-research-synthesis